Biologx's Proprietary Insulin Production Can Save Lives
When we set out to make high-quality insulin affordable, we worked hard to eliminate inefficiencies throughout the production process. BiologX has devised unique processes for the production of recombinant human insulin (RHI) that enable us to make more insulin in a shorter period of time – all at affordable costs to patients worldwide. Our life-saving insulins will meet or exceed USP Reference Standards, the highest quality standards in the market.
BiologX will price our Insulin less than the current market price - because we believe it’s essential to enable easy affordable access to Insulin and because we can make a reasonable profit while doing so.
Want to help us save lives with affordable insulin?
Click the button below to invest in Biologx through our Reg-A+ offering.